您的位置: 首页 > 农业专利 > 详情页

TREATMENT AND/OR PROPHYLAXIS OF DISEASES ACCOMPANYING IMMUNE DISORDER CAUSED BY COMBINATION OF BIGUANIDE-BASED ANTIDIABETIC DRUG AND IMMUNOSUPPRESSANT-RELEASING AGENT OR CO-STIMULATORY RECEPTOR AGONIST
专利权人:
ONO PHARMACEUT CO LTD;OKAYAMA UNIV;小野薬品工業株式会社;国立大学法人 岡山大学
发明人:
UDONO HEIICHIRO,鵜殿 平一郎,EIKAWA SHINGO,榮川 伸吾,TOYOOKA SHINICHI,豊岡 伸一
申请号:
JP2017083767
公开号:
JP2017165752A
申请日:
2017.04.20
申请国别(地区):
JP
年份:
2017
代理人:
摘要:
PROBLEM TO BE SOLVED: To provide a method for activating various immune cells ex vivo to enhance their functions and a method for evaluating multi-functionality of cells related to immunity.SOLUTION: According to the present invention, there is provided a method for enhancing the multi-functionality of Immune cells, the method comprising treating collected immune cells with a biguanide-based antidiabetic drug selected from metformin, phenformin, and buformin in vivo to increase the number of CD8T cells having high IL-2, TNFα and IFNγ producing abilities. There is also provided a method for enhancing the functions of immune cells. Here, the immune cells are selected from CD8T cells, CDT cells, NK cells, γδT cells, NKT cells, B cells, and bone marrow cells. There is also provided a method for treating and/or preventing a disease associated with immune abnormality using immune cells with enhanced functions as an active ingredient. There is further provided a method for evaluating the multi-functionality of immune cells. Here, immune cells treated with a biguanide-based antidiabetic drug selected from metformin, phenformin, and buformin are compared with control immune cells not treated with biguanide-based antidiabetic drug with respect to their multifunctionality.SELECTED DRAWING: None【課題】各種免疫細胞をex vivoで活性化し、機能を増強する方法及び免疫に関する細胞の多機能性評価方法の提供。【解決手段】採取した免疫細胞をメトホルミン、フェンホルミン及びブホルミンから選択したビグアニド系抗糖尿病薬により、in vitroで処理して、IL-2、TNFα及びIFNγの産生能が高いCD8+T細胞を増加させる、免疫細胞の多機能性の増強方法。免疫細胞がCD8+T細胞、CD4T細胞、NK細胞、γδT細胞、NKT細胞、B細胞及び骨髄細胞から選択される細胞である免疫細胞の機能増強法。機能を強強された免疫細胞を有効成分として、免疫異常に伴う疾患の治療及び/又は予防する方法。メトホルミン、フェンホルミン及びブホルミンから選択したビグアニド系抗糖尿病薬で処理した免疫細胞と、ビグアニド系抗糖尿病薬で処理していない対照の免疫細胞の多機能性を比較する、免疫細胞の多機能性の評価方法。【選択図】なし
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充